The Cancer50Pledge in the Offering
Section titled “The Cancer50Pledge in the Offering”Placement strategy · v1
The governing principle
Section titled “The governing principle”Discoverable, never deployed.
A survivor’s pledge used as a persuasion device reads as leveraging a personal event for commercial advantage — and the people most likely to read it that way are exactly the sophisticated advisors and institutional partners you are targeting, who are trained to be sceptical of emotional appeals inside a sales context.
The distinction that matters:
| Cause marketing | Structural commitment |
|---|---|
| Buy this, and we donate | This is how the business is built |
| Transactional | A fact about the entity |
| Appears next to a call to action | Appears where nothing is being asked |
| Weakens when examined | Strengthens when examined |
Yours is the second kind — 50% of net profits, forever, publicly allocated, modelled on Giving What We Can. The moment it appears adjacent to an ask, it converts to the first kind. That is the whole risk, and it is entirely a placement problem.
The paradox worth holding: the pledge does its work precisely to the degree it is not deployed. An advisor who discovers it on their own draws a conclusion. An advisor who is told it draws a different one.
First, the scope work — decided, and more urgent than it looks
Section titled “First, the scope work — decided, and more urgent than it looks”The pledge as published is anchored to MyBetterRates — “50% of every dollar MyBetterRates ever earns.” MBR has been abandoned in favour of Smart Debt Coach and Market Drop Wins, and the site will be generalized. That decision is made.
Worth being clear that this is not a wording refresh. With MBR gone, the pledge as currently written has no live business behind it. A reader who follows the link today finds a commitment tied to a venture that no longer operates, and the reasonable conclusion is that the pledge is dormant. For the audience where it matters most — institutional partners running diligence — that is worse than no page at all.
So the generalization is what keeps the pledge alive, not a tidy-up. Three things it needs:
1. The commitment restated across ventures, not tied to a single business. Same terms: 50% of net profits, forever, publicly allocated.
2. Net profits defined precisely, in writing. Across entities, before a partner’s finance team asks — and they will.
3. The WealthCare 50 Alliance rewritten. It currently offers partners access to MBR’s Benefit Snapshot tools, which no longer exist. The Alliance should become the umbrella, with Market Drop Wins and Smart Debt Coach materials among what partners gain.
One practical note: the page sits on a .pages.dev subdomain while the footer refers to Cancer50Pledge.ca. If partners are going to check it — and that is the whole point — it should live at the permanent domain before it appears in any partnership conversation.
Why it belongs here at all — the coherence argument
Section titled “Why it belongs here at all — the coherence argument”This is the part that makes the placement defensible rather than opportunistic.
The pledge is not a bolt-on to this project. It is the same disposition that produced the rest of it:
- Publishing a negative result you generated yourself, because it is true — the rejected convexity test
- Giving the harmful list away free, because withholding “here is what will hurt you” behind a paywall conflicts with Client First
- Telling advisors that most clients never need to go past tier 1
- Including “how to leave an underperforming advisor” in an advisor-delivered process
- Naming the 2022 problem that breaks your own framework
Each of those costs something and each was chosen anyway. The pledge is that same choice expressed financially. So when it does appear, the right frame is not look what we give but this is consistent with everything else here — and the consistency is checkable, which is what makes it credible.
That framing also means it never needs to be argued. It sits alongside evidence a reader has already encountered.
Placement in the advisor offering
Section titled “Placement in the advisor offering”Where it goes
Section titled “Where it goes”On the licence, invoice or receipt. The strongest placement, and the least obvious one. “50% of net profits from this product are directed to cancer research.” It appears after the decision, in the least promotional context that exists. That is the literal definition of discoverable rather than deployed.
In the About section, one factual paragraph. Not a story, not a hero panel — the same register you used when you mentioned it to me.
In the annual allocation report, sent to licensees as information rather than as marketing. This one compounds: a licensee who receives a plain accounting each year, unprompted, forms a view of the business that no sales page produces.
Where it does not go
Section titled “Where it does not go”- The sales page hero. An advisor deciding whether a process works does not care, and leading with it signals the product needs help.
- The recruitment note. You are asking three friends for a favour. Adding a cause makes the favour harder to decline for the wrong reason.
- The reference card, the Inventory, the plan, the checklist. These carry the advisor’s brand in a client meeting. Yours does not belong there.
- Anywhere near the referral ask. “Would you refer someone — and we donate to cancer research” is the exact transactional collapse the principle exists to prevent.
The test: if removing the pledge from a page would weaken the persuasive case, it is in the wrong place.
Placement in distribution and partnership
Section titled “Placement in distribution and partnership”Your instinct is right, and I think you have understated it. This is where the pledge leads rather than follows.
Why it works with institutions specifically
Section titled “Why it works with institutions specifically”A money manager, dealer or investment lender evaluating a partnership with a solopreneur promoting leverage-adjacent strategies runs an unstated risk assessment: who is this person, what is their motive, and what happens to our brand if this goes wrong?
Credentials do not answer that. Track record partially answers it. A public, permanent, independently checkable commitment answers it in a register nothing else reaches — because it is costly, verifiable, and cannot be adopted retroactively.
Second reason: financial firms have CSR and ESG mandates and genuinely struggle to find authentic partnerships. Most corporate giving is bolted on and everyone involved knows it. A founder-level survivor pledge with published allocations is scarce, and scarcity is what a partnership team is actually shopping for.
The WealthCare 50 Alliance as the vehicle
Section titled “The WealthCare 50 Alliance as the vehicle”The structure already exists. Two observations.
It is currently framed around MBR’s Benefit Snapshot tools. If the pledge extends across ventures, the Alliance should become the umbrella rather than an MBR feature — with Market Drop Wins and Smart Debt Coach materials among what partners gain access to.
The commitment bar is high, and that will limit participation. Asking a firm to direct a percentage of profits touches financial reporting and needs board approval. That is a long sale with a small number of possible yeses.
Consider tiers, without weakening the founding commitment:
- Full pledge — a percentage of profits. The headline tier.
- Fixed commitment — a defined annual amount. Board-friendly, comes from a marketing or CSR budget, and clears in weeks rather than quarters.
- Matching — the firm matches allocations generated through its channel. Naturally scales with the partnership and is easy to explain internally.
The founding tier stays as it is. The lower rungs exist so a firm that wants to participate has a route that does not require restructuring its accounts.
Three cautions
Section titled “Three cautions”1. The verification promise creates an obligation. “Published annually, verified allocations” is a commitment. A year passing without a published allocation converts the pledge from an asset into a liability, and it is the kind of thing a partner’s diligence team checks. Build the reporting cadence before the pledge appears in any partnership conversation.
2. Do not construct a thematic link between cancer and market declines. There is a temptation — resilience, recovery, surviving downturns. It would be crass and it would be noticed. The connection is the person, not the subject matter. Leave it entirely alone.
3. Watch the reinvestment arithmetic. Fifty percent of net profits is a real constraint on a business that needs product development, and Market Drop Wins has more build ahead of it than MBR did. That is your commitment and I am not questioning it — but define net profits precisely, in writing, before a partner’s finance team asks. Ambiguity discovered later damages the thing the pledge exists to protect.
In one line
Section titled “In one line”Advisor offering: present after the decision, never before it. Licence, About, annual report. Nowhere else.
Distribution and partnership: present early, as a fact about who you are — because for an institution assessing a small partner, it answers the question they cannot politely ask.